c-FLIP Protects Cardiac Microcirculation in Sepsis-Induced Myocardial Dysfunction Via FUNDC1-Mediated Regulation of...

Area of Science:

• Cardiovascular Biology
• Cellular Biology
• Mitochondrial Dynamics

Background:

• Sepsis-induced myocardial dysfunction (SIMD) is a severe complication with limited therapeutic options.
• Cardiac microcirculation and mitochondrial function are critical in SIMD pathogenesis.
• The role of cellular FLIP (c-FLIP) in SIMD remains largely unexplored.

Purpose of the Study:

• To investigate the role of c-FLIP in sepsis-induced myocardial dysfunction (SIMD).
• To elucidate the mechanisms by which c-FLIP influences cardiac microcirculation and mitochondrial autophagy in SIMD.
• To evaluate the therapeutic potential of modulating c-FLIP in SIMD.

Main Methods:

• Utilized sepsis-induced myocardial dysfunction (SIMD) rat models.
• Employed lipopolysaccharide (LPS)-induced cardiac microvascular endothelial cell injury models.
• Analyzed the impact of c-FLIP deficiency and overexpression on mitochondrial homeostasis, autophagy, and inflammation.

Main Results:

• c-FLIP deficiency disrupted mitochondrial homeostasis and exacerbated microcirculatory damage in SIMD.
• c-FLIP was found to differentially regulate mitochondrial autophagy via FUNDC1.
• Overexpression of c-FLIP balanced mitochondrial autophagy, protected mitochondria, reduced inflammation, and ameliorated SIMD.

Conclusions:

• c-FLIP plays a crucial role in maintaining mitochondrial homeostasis and cardiac function during sepsis.
• Modulating c-FLIP offers a promising therapeutic strategy for sepsis-induced myocardial dysfunction.
• Targeting c-FLIP may protect cardiac mitochondria and improve outcomes in sepsis patients.